Asia Pacific Long Read Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Consumables, and Services), By Technology (Single Molecule Real Time Sequencing, Nanopore Sequencing, and Others), and Asia Pacific Long Read Sequencing Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Long Read Sequencing Market Insights Forecasts to 2035

• The Asia Pacific Long Read Sequencing Market Size Was Estimated at USD 85.9 Million in 2024.
• The Market Size is Growing at a CAGR of 24.9% between 2025 and 2035.
• The Asia Pacific Long Read Sequencing Market Size is Anticipated to Reach USD 991.5 Million by 2035.

According to a research report published by Spherical Insights & Consulting, the Asia Pacific long read sequencing market is anticipated to Hold USD 991.5 Million by 2035, growing at a CAGR of 24.9% from 2025 to 2035. The Asia Pacific region's long read sequencing Market has several opportunities due to increased interest in genomics research, increased diagnostic of rare diseases, a larger acceptance of precision medicine as well as increasing amounts of investment in the biotech sector. Accurate detection of structural variants within the rapidly evolving healthcare marketplace will be essential moving forward.

Market Overview

The Asia Pacific long read sequencing market is part of the growing trend in developing more accurate sequencing technology to allow scientists to detect structural modifications, genomic complexity and identify full length transcript coding across Asia Pacific. This growing market has been fueled by an increase in Genomic Research and access to genomic research to create Precision Medicine in countries such as China, Japan, India, and South Korea. Long read sequencing uses longer DNA sequences which allows researchers to study more complex and higher resolution traits, including Transcriptomics and Epigenomics, than short-read sequencing technology. In addition to increasing levels of investment in Biotech, there are also many researchers from around the globe working together to advance research initiatives, open up Genomic Research Centers and invest in creating Genomic Research Centers and expanding research capacity to carry out Genomic Research across Asia Pacific. Additionally, government investment towards the advancement of genomic medicine and the demand for innovative clinical diagnostics are further driving the growth of the market in this region.

Report Coverage

This research report categorizes the market for the Asia Pacific long read sequencing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific long read sequencing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific long read sequencing market.

Driving Factors

The Asia Pacific long read sequencing market will be driven by increased levels of research in genomics and transcriptomics, continued to increase the demand for Precision Medicine, and increased prevalence of genetics and Rare Disease. In addition, the increased investment in Biotechnology, as well as improvements in Research Infrastructure and Government Support for Genomic Medicine will lead to the accelerated adoption of these technologies. Furthermore, the long read sequencing method has shown superior accuracy over short read methods in detecting structural variants, repetitive regions, and full-length transcripts, which will continue to contribute to growth in the long read sequencing market across Asia, including China, Japan, India, and South Korea.

Restraining Factors

The Asia-Pacific market for long read sequencing encounters various constraints. High prices for instruments and consumables, a lack of technical expertise, and the complexity of data analysis are a few examples. Furthermore, slow adoption at smaller research facilities as well as limited infrastructure in developing regions can impede overall growth within the long read sequencing sector in Asia-Pacific.

Market Segmentation

The Asia Pacific long read sequencing market share is classified into product and technology

• The instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific long read sequencing market is segmented by product into instruments, consumables, and services. Among these, the instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Instruments held a major share in 2024 because sequencing platforms are essential for genomics research and diagnostics. Consumables are projected to grow fastest due to recurring usage in workflows, increasing research projects, and widespread adoption of long read sequencing technologies.

• The single molecule real time sequencing segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific long read sequencing market is segmented by Technology into single molecule real time sequencing, nanopore sequencing, and others. Among these, the single molecule real time sequencing segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Single Molecule Real Time (SMRT) Sequencing held a significant share in 2024 due to its high accuracy, ability to generate long reads, and strong adoption in genomics, transcriptomics, and clinical research across Asia Pacific.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific long read sequencing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• MicrobesNG
• Element Biosciences
• Quantapore
• BGI Group
• Oxford Nanopore Technologies PLC
• Huawei Technologies
• Pacific Biosciences of California Inc
• New England Biolabs

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Europe, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific long read sequencing market based on the following segments:

Asia Pacific Long Read Sequencing Market, By Product

• Instruments
• Consumables
• Services

Asia Pacific Long Read Sequencing Market, By Technology

• Single Molecule Real Time Sequencing
• Nanopore Sequencing
• Others